Tools
Stock profile

ICF International, Inc. (ICFI)

ICFI · Latest close $77.96 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$77.96
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
0
vs previous quarter

ICF International, Inc. (ICFI) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $995.4K sold). Latest close $77.96 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 10, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-995.4K
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Third Avenue Management — 1 tracked fund hold ICFI. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 4 sales ($995.4K). Insider trading

Often held alongside

Genpact LTD (G) · Booz Allen Hamilton Holding Corp (BAH) · FTI CONSULTING, INC (FCN) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Third Avenue Management1.15%98,893ADDED (+37.9%) Q3 filed Nov 13

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +7.7% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

139.1956.732024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding232 of 8,857 filers
Long-only filers among them232
Change vs 2026 Q1-8 net · 226 entered · 234 exited
Shares reported, all filers18,337,800
Reported value, all filers$1.3B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryServices-Management Consulting Services (SIC 8742)
Revenue · FY2025$1.9B
Net income · FY2025$91.6M
Total assets · FY2025$2.1B
Shares outstanding17,933,884
Market cap (at latest close)$1.4B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 2026655,697
Share of shares outstanding3.66%
Days to cover4.10

Shares short at recent settlements — Jul 31, 2026: 610K · Aug 14, 2026: 669K · Aug 31, 2026: 636K · Sep 15, 2026: 612K · Sep 30, 2026: 778K · Oct 15, 2026: 656K.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 6 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 4 sales by 3 insiders ($995.4K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 10, 2026Morgan James C MChief Oper. & Fin. OfficerSell3,000$84.32$253.0KSEC filing
Sep 1, 2026Wasson JohnCEO & PresidentSell585$89.68$52.5KSEC filing
Sep 1, 2026Wasson JohnCEO & PresidentSell5,815$88.18$512.8KSEC filing
Aug 26, 2026Ostria Sergio JExecutive Vice PresidentSell2,000$88.59$177.2KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 1, 2026JOHN M WASSON REMAINDER TR 2022Director, Officer6,400$570.2KSep 1, 2026SEC filing
Aug 26, 2026SERGIO OSTRIAOfficer2,000$177.2KAug 26, 2026SEC filing
Jul 13, 2026JOHN M WASSON REV TRUST U/A DTD 12/02/2020Director, Officer12,411$953.5KJul 13, 2026SEC filing
Sep 25, 2025JAMES C MORGANOfficer2,500$237.1KSep 25, 2025SEC filing
May 12, 2025JAMES C MORGANOfficer2,500$218.8KMay 12, 2025SEC filing
May 9, 2025JAMES C MORGANOfficer2,500$217.5KMay 9, 2025SEC filing
Nov 6, 2024JOHN M WASSON REV TRUST U/A DTD 12/02/2020Director, Officer2,121$362.7KNov 6, 2024SEC filing
Nov 6, 2024ANNE F CHOATEOfficer1,438$245.9KNov 6, 2024SEC filing
Oct 16, 2024JAMES C MORGANOfficer2,500$420.0KOct 16, 2024SEC filing
Aug 29, 2024JOHN M WASSON REV TRUST U/A DTD 12/02/2020Director, Officer3,000$489.9KAug 29, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 14, 2026AllianceBernstein L.P.SC 13G1,417,2307.8%Jun 30, 2026SEC filing
Aug 12, 2026Capital Research Global InvestorsSC 13G/A243,2021.3%Jun 30, 2026SEC filing
Aug 6, 2026FMR LLCSC 13G1,157,354.336.4%Jun 30, 2026SEC filing
Jul 15, 2026Wasatch Advisors LPSC 13G/A578,4453.2%Jun 30, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G950,5295.2%Mar 31, 2026SEC filing
Apr 9, 2026Dimensional Fund Advisors LPSC 13G978,4555.4%Mar 31, 2026SEC filing
Apr 6, 2026Wasatch Advisors LPSC 13G/A1,174,8506.4%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Nov 13, 2025Capital Research Global InvestorsSC 13G/A1,607,4618.7%Sep 30, 2025SEC filing
Nov 13, 2025Wasatch Advisors LPSC 13G/A2,594,21514.1%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-Management Consulting Services (SIC 8742). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 65 Lobbying Disclosure Act filings named this company as client, 2007–2026; most common issues: Government Issues (27), Housing (24), Energy/Nuclear (9).

Federal contracts: $3.4B in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$626.1M
FY2022$653.5M
FY2023$713.9M
FY2024$641.4M
FY2025$387.8M
FY2026$422.7M

Largest awards collected

Award IDAgencyAmountStart
DTOS5915P00043Department of Transportation$100.0KSep 25, 2015

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Greenblatt Magic Formula — High earnings yield and high return on capital together

· Dividend Growth — Dividends raised for more than 10 years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Earnings Stability — Small earnings swings and almost no loss years

Key figures

· Greenblatt Magic Formula — Earnings yield: 5.2% · Return on capital: 86.3% · Combined rank: 50

· Dividend Growth — Dividend per share: 0.56 · Dividend yield: 0.6% · Straight dividend years: 8 · 10-yr dividend growth: —

· Cash Flow (FCF) — Latest FCF: $120.2M · FCF yield: 6.8% · Positive FCF years: 3

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.65 · Operating cash flow: $141.9M · Net income: $91.6M

· Earnings Stability — Earnings variation (CV): 0.25 · Loss years (of 10): 0 · Latest net income: $91.6M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Also held by the tracked funds that hold ICFI — ranked by lift, the co-holding pattern described in Methodology: Genpact LTD (G) · Booz Allen Hamilton Holding Corp (BAH) · FTI CONSULTING, INC (FCN) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) · VSE CORP (VSEC) · Medpace Holdings, Inc. (MEDP) · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 5, 20262.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Sep 24, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 6, 20262.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Genpact LTD (G) · Track Record: how the signals scored · Practice timing on ICFI

One email a week: the week’s new filings and research. Subscribe free

← ICE  ·  ICHR →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.